Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (2049)	2/17/2002 1:40:32 AM
From: lifeisgood	Respond to of 2515

Icahn's "interest" in IMCL is total BS and it looks like Waksal himself dreamt this ploy up. Icahn's feigned "interest" is merely a ploy to pressure BMY to agree to favorable restructuring terms with Waksal (i.e., keep him on IMCL payroll rather than kick him and his bro to the curb). It's not going to work because BMY knows very well that if they ditch IMCL, no one else will touch this company with a ten foot pole. Icahn may be a tennis buddy of Waksal's but he's not going to throw his money into a rathole for him. Also, the whole shareholder rights deal is an old dot.com company trick to try to portray a company as attractive to potential buyers. It didn't work for the dot.coms and it's not going to work for IMCL. Believe me, no one is looking to buy IMCL with all of it's current baggage. IMCL has always been a one-trick pony and now it looks like that trick was bogus from the start. best... LIG